SEP 22, 2015 11:37 AM PDT

Cancer-Suppressing Gene

WRITTEN BY: Ilene Schneider
Researchers at the University of Adelaide in Australia have discovered the role played by a gene that suppresses the development of cancer. Their work, which was published in the journal PLOS One and reported in Drug Discovery & Development, offers a variety of new opportunities for scientists to develop treatments for cancer. At the crux of the research is the activity of the gene WWOX.
Protein in gene can suppress cancer by altering metabolism. 
According to Professor Rob Richards, Head of Genetics and Evolution in the University’s School of Biological Sciences, “We’ve known for some time that in certain types of cancer, people with low levels of WWOX protein are more likely to develop cancer. We also know that cancers with low levels of WWOX tend to be more aggressive and less responsive to treatment. A higher level of WWOX activity is definitely a good thing to have, but, until now, the role that WWOX plays in cancer suppression has been a mystery.”
 
Working with his team of researchers, Dr Louise O’Keefe and Ph.D. students Amanda Choo and Cheng Shoou Lee, Professor Richards studied the impact of lower levels of WWOX on cells using a genetic model: the small laboratory fly, Drosophila. As Professor Richards explained, “Our research has shown that cancer cells with lower levels of WWOX had a competitive advantage over those cells with normal WWOX levels, and could outgrow them. This could lead to a more aggressive cancer and worse outcomes for cancer patients: poorer survival rates.”
 
After additional research, the scientists saw that the WWOX gene plays a role in the altered metabolism of cancer cells that are known to use glucose differently from normal cells. Cancer cells are likely to use glucose to create more cell building blocks than energy, and this process is what is assumed to help them to divide and grow. 
 
Professor Richards added, “Another set of Drosophila experiments revealed that the WWOX gene helps keep the balance of glucose use in favour of producing energy rather than helping cancer cells multiply. This difference in metabolism is a key part of how cancer cells have a competitive advantage over normal cells. Low WWOX levels will allow more glucose to be used for these cancer cell building blocks.”
 
The research offered good news: is that WWOX belongs to a family of proteins that have enzyme activity. Thus, WWOX activity can be altered by targeting the enzyme.
 
“We now have a good idea of what WWOX does in cancer cells and how it acts to help suppress cancer. And we have a potential target to be able to influence that activity to change the properties of cancer cells,” Professor Richards concluded.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
NOV 20, 2019
Genetics & Genomics
NOV 20, 2019
Mining 'Junk' DNA for New Cancer Therapeutics
There are vast portions of the genome that don't code for protein, but researchers are learning more about how important they are....
DEC 06, 2019
Health & Medicine
DEC 06, 2019
Study finds association between hair products and breast cancer risk
For many women, hair color and style are significant components of their identity. However, troubling information from a new study about the use of hair dy...
JAN 02, 2020
Drug Discovery & Development
JAN 02, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 02, 2020
Cancer
JAN 02, 2020
Early onset stomach cancer in young people
New research from Mayo Clinic published recently in the journal Surgery details a distinction in the types of stomach cancer that affects particularly youn...
JAN 24, 2020
Immunology
JAN 24, 2020
Immune "Recycling" Could Improve Cancer Immunotherapy
A natural housekeeping function performed by many cells of the human body, including those in the immune system, is under intense scrutiny for its potentia...
FEB 04, 2020
Cancer
FEB 04, 2020
The role of SRR in colorectal cancer
Researchers from Osaka University have recently discovered a new function of the multifunctional enzyme entitled serine racemase (SRR). According to the te...
Loading Comments...